At the IFSCC Congress in Cannes from September 15 to 18, INNOV&SEA will present its innovative in vitro marine ecotoxicity testing technology, developed to help the cosmetics industry evaluate and reduce the environmental impact of their products, particularly on sensitive marine ecosystems such as coral reefs.
Every year, an estimated 4,000 to 6,000 tons of sunscreen are released into the oceans, contributing to marine pollution and threatening biodiversity. As environmental awareness grows, so does the demand for scientifically validated environmental claims. Yet most current methods to assess marine toxicity rely on live animal testing or are insufficiently adapted to coastal ecosystems.
INNOV&SEA has developed the first in vitro marine ecotoxicity test using Anemonia viridis cell cultures, a coralrelated marine organism. This innovative solution allows brands and formulators to assess the impact of raw materials such as UV filter but also finished products early in the development process, ensuring safer formulations for marine life.
By using cell cultures instead of live organisms, this test offers an ethical, reproducible, and rapid solution, aligned with global sustainability goals and the cosmetics industry’s increasing commitment to eco-responsibility.
“Brands are under growing pressure to justify environmental claims with robust scientific evidence, especially in light of new antigreenwashing regulations,” explains Dr. Pauline Cotinat, CEO of INNOV&SEA. “Our method provides reliable data that supports eco-design and transparent communication.”
INNOV&SEA already collaborates with leading cosmetic brands and ingredient suppliers, contributing to a new standard in product development that combines innovation with ocean protection.
📍Meet the INNOV&SEA team at IFSCC Congress 2025 in Cannes to learn more about marine-friendly testing solutions.
Advertorial
CONTACT
INNOV&SEA
61 avenue Simone Veil 06200 Nice, France
contact@innovandsea.com / https://innovandsea.com
Discover their latest services during the exclusive webinar and the latest evaluation trends and innovations in preclinical trials and clinical studies.